Skip to main content
. 2021 May 11;12:2726. doi: 10.1038/s41467-021-22877-8

Table 3.

Study-level demographic information (Echocardiogram cohort).

BWH MGH UCSF NW Keio
Case Control Case Control Case Control Case Control Case Control
Number of studies 1486 3079 110 331 46 323 103 126 118 121
Age, years ± SD 72.9 ± 8.8 65.4 ± 14.5 71.9 ± 9.7 70.2 ± 12.3 70.3 ± 11.6 67.0 ± 12.8 75.1 ± 7.4 74.7 ± 7.6 74.2 ± 8.2 73.8 ± 8.5
  Age Groups
   ≤30, n (%) 0 (0.0) 70 (2.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
   30–50, n (%) 25 (1.7) 381 (12.4) 7 (6.4) 36 (10.9) 3 (6.5) 37 (11.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
   50–70, n (%) 477 (32.1) 1363 (44.3) 34 (30.9) 108 (32.6) 15 (32.6) 137 (42.4) 27 (26.2) 39 (31.0) 30 (25.4) 34 (28.1)
   70–90, n (%) 971 (65.3) 1228 (39.9) 69 (62.7) 181 (54.7) 28 (60.9) 149 (46.1) 75 (72.8) 87 (69.0) 86 (72.9) 83 (68.6)
   >90, n (%) 13 (0.9) 37 (1.2) 0 (0.0) 6 (1.8) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0) 2 (1.7) 4 (3.3)
   HR, bpm ± SD 74.5 ± 18.4 71.1 ± 18.7 79.4 ± 21.5 71.4 ± 16.1 78.0 ± 14.7 74.1 ± 21.9 74.7 ± 19.5 63.8 ± 9.9 71.8 ± 17.0 69.4 ± 15.4
Manufacture
   Philips, n (%) 272 (18.3) 2340 (76.0) 105 (95.5) 313 (94.6) 44 (97.5) 312 (96.6) 0 (0.0) 0 (0.0) 48 (40.7) 38 (31.4)
  GE, n (%) 1204 (81.0) 724 (23.5) 5 (4.5) 18 (5.4) 2 (4.3) 11 (3.4) 103 (100.0) 126 (100.0) 47 (39.8) 57 (47.1)
  Agilent, n (%) 3 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  SonoSite, n (%) 1 (0.1) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
  SIEMENS, n (%) 6 (0.4) 15 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 TOSHIBA, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 23 (19.5) 26 (21.5)

HR heart rate, BWH Brigham and Women’s Hospital, MGH Massachusetts General Hospital, UCSF University of California San Francisco, NW Northwestern University, Keio: Keio University Hospital. N represents the number of studies.